Stance Capital’s Hologic HOLX Stock Holding History

Stance Capital’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-686	Closed	-$46.3K	–	200
2025 Q3	$46.3K	Buy	+686	New	+$45.5K	0.02%	176

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Stance Capital's HOLX Position: Q4 2025 in Review

Stance Capital sold out of Hologic (HOLX) in Q4 2025, closing a stake of 686 shares — an estimated $46.3K sold.

Stance Capital first reported a position in HOLX in Q3 2025 and held it in 1 quarter. The position peaked at $46.3K in Q3 2025. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

Stance Capital reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
Stance Capital sold 686 Hologic shares in Q4 2025, an estimated $46.3K.
Stance Capital first reported a position in Hologic in Q3 2025 and held it in 1 quarter.
Stance Capital's Hologic position peaked at $46.3K in Q3 2025.
749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Stance Capital's 13F filing for Q4 2025, filed 17 Mar 2026.